Medical Industry Feature

00:04:30

Single-Port Robotics Improves Outcomes for Thoracic...

Medical Industry Feature ·

2026/10/02

Guest: Benjamin Lee, M.D. Guest: Jeffrey Port, M.D. Guest: Jonathan Villena-Vargas, M.D. Surgeons at NewYork-Presbyterian and Weill Cornell Medicine are advancing the use of single-port robotics for complex thoracic surgery. While multiport robotic surgery requires 4-5 incisions around the ribs, the single-port platform uses one incision through the diaphragm, improving surgery success and reducing recovery time. By being an early adopter, the center at NewYork-Presbyterian and

en

00:13:19

Vitreous Hemorrhage Following PVD: Who Needs Surgery?

Medical Industry Feature ·

2026/09/23

Host: Barton Lynn Blackorby, MD Guest: Kyle Davis Kovacs, MD Guest: Matthew Starr, MD How aggressively should you manage a vitreous hemorrhage after a PVD when you can't see the retina underneath it? Barton Blackorby, MD, moderates a discussion with Matt Starr, MD, and Kyle Kovacs, MD, about a study published in Ophthalmology by Hasbolat et al examining 366 patients with PVD-related vitreous hemorrhage initially managed with observation. The panel discusses how exam technique

en

00:19:15

Groundbreaking Gene Therapy Restores Natural Hearing...

Medical Industry Feature ·

2026/09/17

Guest: Lawrence Lustig, M.D. On this episode of Advances in Care, Erin Welsh speaks with Dr. Lawrence Lustig, otolaryngologist-in-chief at NewYork-Presbyterian and Columbia. Dr. Lustig has spent decades working to advance various interventions to treat genetic deafness and after years of research, his team was the first to show that gene therapies could be effective at reversing hearing loss in mouse models. Dr. Lustig focused his initial study on otoferlin, a gene that is missing in

en

00:06:15

Does Preoperative Anti-VEGF Change Outcomes in...

Medical Industry Feature ·

2026/09/03

What happens when vitreous hemorrhage (VH) secondary to non-tractional PDR doesn't clear on its own? And does preoperative anti-VEGF actually change surgical outcomes? Maria Berrocal, MD, speaks with Sumit Sharma, MD, about a retrospective case series of 360 patients who underwent vitrectomy for non-clearing VH without tractional elements, examining whether preoperative anti-VEGF injection affects the risk of postoperative rebleeding, when to consider repeat vitrectomy, and how both

en

00:17:00

The Positive Impact of Electroconvulsive Therapy for...

Medical Industry Feature ·

2026/08/24

Guest: Leonardo Lopez, M.D. On this episode of Advances in Care, Erin Welsh is joined by Dr. Leonardo Lopez, a psychiatrist at NewYork-Presbyterian and vice chair for inpatient services in the Department of Psychiatry at Weill Cornell Medicine. Dr. Lopez and his team are at the forefront of electroconvulsive therapy (ECT) and have built one of the largest programs of its kind in the country dedicated to treating severe psychiatric illness through this revolutionary method. Though it is

en

00:11:00

R/R LBCL: A Practical Guide to CAR T Referral and...

Medical Industry Feature ·

2026/08/20

Guest: Loretta J. Nastoupil, MD Guest: Manali Kamdar, MD CAR T cell therapy has been established as a standard-of-care option in the second-line setting for appropriate relapsed/refractory patients with large B-cell lymphoma (LBCL).1 Some outcomes data suggest more favorable outcomes when CAR T is used in the second-line setting compared with subsequent lines of therapy.2,3 That’s why it’s important to not wait to refer and to consult with a CAR T specialist for all on-label

en

00:16:15

The Patient You Might Be Missing: Severe...

Medical Industry Feature ·

2026/08/14

Host: Charles Turck, PharmD, BCPS, BCCCP Guest: Erin D. Michos, MD, MHS Severe hypertriglyceridemia (sHTG) affects more than 3 million people, but it often flies under the clinical radar.1-3 When triglycerides are at or above a 500 mg/dL threshold, it’s no longer just an isolated lab value—it’s a level of hypertriglyceridemia where the clinical implications change, and where a more careful evaluation for underlying causes and risk becomes important.4 That’s why Dr. Charles Turck

en

00:04:20

Secondary IOL Surgery Is Unprofitable Under Current...

Medical Industry Feature ·

2026/08/03

Host: Maria Berrocal How much money are retina surgeons losing on secondary IOL procedures? In this episode of Clinical Minute: Retina, host Maria Berrocal, MD, speaks with Nimesh "Nemo" Patel, MD, whose research uncovered how many cases are unprofitable under current Medicare reimbursement rates, and assess how much cash surgeons burn per case. Dr. Patel discusses the implications for patient access, the advocacy efforts underway through the ASRS Health Economics Committee, and why

en

00:03:30

Cerebral Organoid Model Transforms Glioblastoma Research

Medical Industry Feature ·

2026/07/20

Guest: Howard Fine, M.D. Dr. Howard Fine, a neuro-oncologist at NewYork-Presbyterian and Weill Cornell Medicine, discusses how a new approach to glioblastoma research may expand treatment options and advance precision oncology. His preclinical model, GLICO, uses cerebral organoids, or mini brains, to create a more accurate representation of glioblastoma tumor biology. Through an advanced, high-throughput drug-screening system that Dr. Fine and his team developed, they can screen

en

00:14:58

Clinical Features and Outcomes of IOFB Removal

Medical Industry Feature ·

2026/07/14

What do large registry data reveal about outcomes after intraocular foreign body removal, and how should those findings shape surgical planning and patient counseling? In this episode of New Retina Radio Journal Club with VBS, Jordan Deaner, MD, moderates a discussion with Vaidehi Dedania, MD, and Rehan Hussain, MD, on a 2025 IRIS Registry analysis of nearly 4,800 eyes. The group reviews the delayed timeline of visual recovery, the risk of late complications, and practical guidance on

en

00:04:37

Socioeconomic Determinants and Outcomes in...

Medical Industry Feature ·

2026/07/06

Host: Maria Berrocal Guest: Audina Berrocal, MD Does socioeconomic status influence outcomes in proliferative sickle retinopathy? In this episode of Clinical Minute: Retina, host Maria Berrocal, MD, speaks with Audina "Nina" Berrocal, MD, of Bascom Palmer Eye Institute, who published a retrospective review of more than 100 patients with proliferative sickle retinopathy. They explore whether the integrated care model at Bascom Palmer may account for results that don't translate to

en

00:10:45

Redefining Durability in Wet AMD: Insights from the...

Medical Industry Feature ·

2026/06/17

Host: Priya Vakharia, MD Guest: Andrew Moshfeghi, MD The SOL-1 Phase 3 superiority trial compared the efficacy and safety of the investigational product OTX-TKI (axitinib intravitreal hydrogel) with aflibercept 2 mg. The primary endpoint was proportion of subjects who maintained visual acuity, defined as <15 Early Treatment Diabetic Retinopathy Study letters of best-corrected visual acuity loss from baseline at Week 36. Based on the findings, SOL-1 met its primary endpoint and

en

00:02:15

Expandable Cages Enhance Minimally Invasive Spinal...

Medical Industry Feature ·

2026/05/19

Guest: Ibrahim Hussain, M.D. Neurological spine surgeon Dr. Ibrahim Hussain explains how expandable cages are being used in minimally invasive transforaminal lumbar interbody fusions to optimize patient outcomes. These cages can be inserted with a very low profile to restore height and lordosis, and enable a faster recovery. At Och Spine at NewYork-Presbyterian, surgeons are pursuing innovative solutions to provide a better quality of life for patients with degenerative disc disease

en

00:16:45

ReDiscover-2: Currently Enrolling Patients With...

Medical Industry Feature ·

2026/05/15

Host: Charles Turck, PharmD, BCPS, BCCCP Guest: Sarah Sammons, MD Despite advances in the treatment of HR-positive HER2-negative advanced breast cancer, patients with PIK3CA-mutated disease who progress after a CDK4/6 inhibitor still face limited effective and tolerable treatment options.1 This unmet need has fueled interest in zovegalisib (formerly RLY-2608), a next generation, pan-mutant-selective PI3Kα inhibitor designed to spare wild-type protein and potentially reduce

en

00:21:15

Improving Preterm Birth Outcomes with Virtual Cervix...

Medical Industry Feature ·

2026/05/13

Guest: Mirella Mourad, M.D. On this episode of Advances in Care, host Erin Welsh is joined by Dr. Mirella Mourad, maternal-fetal medicine specialist at NewYork-Presbyterian and co-director of the Preterm Birth Prevention Center at Columbia, to explore a groundbreaking new technology aimed at improving the diagnosis and treatment of preterm birth. Preterm birth impacts approximately 1 in 10 pregnancies in the United States, making it a leading cause of neonatal complications and

en

00:11:30

Engaging Patients and Caregivers About Digital...

Medical Industry Feature ·

2026/05/07

Host: Charles Turck, PharmD, BCPS, BCCCP Guest: Maggie Emerson, DNP, APRN, PMHNP-BC Guiding patients and caregivers through the fast-moving landscape of digital therapeutics can be a challenging but worthwhile part of providing effective and accessible care. That’s why Dr. Charles Turck speaks with Dr. Maggie Emerson about how we can best partner with patients and caregivers around this relatively new treatment in mental health care. Dr. Emerson is a Clinical Associate Professor at

en

00:11:00

From Monoamines to Neurocircuits: Our Evolving...

Medical Industry Feature ·

2026/04/20

Host: Charles Turck, PharmD, BCPS, BCCCP Guest: Joseph Goldberg, MD Our understanding of depression has evolved over the past several decades, leading us to some potential new treatment options that focus on neuroplasticity, chemical imbalance, and negative cognitive biases. Learn more about the history of depression treatment approaches and the emerging concept of neuroplasticity with Dr. Charles Turck and Dr. Joseph Goldberg, Clinical Professor of Psychiatry at the Icahn School

en

00:14:45

Neuroplasticity: A Potential Target for the Treatment...

Medical Industry Feature ·

2026/04/01

Host: Charles Turck, PharmD, BCPS, BCCCP Guest: Madhukar H. Trivedi, MD The brain is constantly changing as a result of experience, stress, emotional processing, learning, and memory.1 And neuroplasticity adds another layer to these approaches by focusing on what’s actually changing in the brain.2 Tune in with Dr. Charles Turck as he speaks with Dr. Madhukar Trivedi, Founding Director of the Center for Depression Research and Clinical Care and Chief of the Division of Mood

en

00:18:00

Breakthrough Technology Improves Concussion...

Medical Industry Feature ·

2026/03/30

Guest: Thomas S. Bottiglieri, D.O. On this episode of Advances in Care, host Erin Welsh sits down with Dr. Thomas Bottiglieri, Chief of the Primary Care Sports Medicine Division at NewYork-Presbyterian and Columbia, to discuss the evolving landscape of concussion care—from prevalence to emerging diagnostic breakthroughs. With over 2 million estimated concussions occurring annually in the United States and many of them affecting young athletes, Dr. Bottiglieri and his colleagues have

en

00:05:00

Groundbreaking AI Models Transform Cardiovascular...

Medical Industry Feature ·

2026/03/24

Guest: Pierre Elias, M.D. Learn how Dr. Pierre Elias and his team at NewYork-Presbyterian and Columbia have established a deep learning lab called CRADLE, which uses basic medical imaging, EKGs, and echocardiograms to build advanced AI models that help identify all forms of structural heart disease, including cardiac amyloidosis and valvular regurgitation. These tools not only improve screening access but enable early detection. © 2026 NewYork-Presbyterian

en

All Episodes

Similar Podcasts

天方烨谈

基因频道

Quilo de Ciencia - Cienciaes.com

Jorge Laborda

The Field Guides

The Field Guides

Ciência

RFI Português

Mendelspod Podcast

Theral Timpson